tert-Butyl 4-(6-Nitropyridin-3-yl)piperazine-1-Carboxylate CAS 571189-16-7 Purity >98.0% (HPLC) Palbociclib Intermediate Factory
I-Ruifu Chemical Supply Palbociclib Related Intermediate:
I-Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5
5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butyl 4-(6-Nitropyridin-3-yl)piperazine-1-Carboxylate CAS 571189-16-7
tert-Butyl 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7(8H)-one CAS 1016636-76-2
2-Chloro-8-Cyclopentyl-5-Methyl-8H-Pyrido[2,3-d]pyrimidin-7-one CAS 1013916-37-4
Igama Lekhemikhali | I-tert-Butyl 4-(6-Nitropyridin-3-yl)piperazine-1-Carboxylate |
Omqondofana | I-1-Boc-4-(6-Nitro-3-Pyridyl)piperazine;4-(6-Nitro-3-pyridinyl)-1-Piperazinecarboxylic Acid tert-Butyl Ester;i-tert-Butyl 4-(6-Nitro-3-Pyridinyl)-1-Piperazinecarboxylate |
Inombolo ye-CAS | 571189-16-7 |
Inombolo yeCAT | I-RF-PI1850 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | I-C14H20N4O4 |
Isisindo samangqamuzana | 308.33 |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Impushana Ensundu Ekhanyayo ukuya Ensundu |
Ukuhlanzeka / Indlela Yokuhlaziya | >98.0% (HPLC) |
I-LCMS | Ihambisana Nesakhiwo |
Ukulahlekelwa Ekumisweni | <1.00% |
Ukungcola Okuphelele | <2.00% |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-Intermediate of Palbociclib (CAS: 571190-30-2) |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama
I-tert-Butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate (CAS: 571189-16-7) iyindawo emaphakathi ye-Palbociclib (CAS: 571190-30-2).I-Palbociclib (eyaziwa nangokuthi inombolo ehlanganisiwe PD-0332991) isidakamizwa esihlolwayo sokwelapha umdlavuza webele esakhiwa yi-Pfizer.Kuyi-inhibitor ekhethiwe ye-cyclin-dependent kinases CDK4 ne-CDK6.I-Palbociclib ivimba ukuqhubeka komjikelezo weseli ukusuka kusigaba G1 ukuya ku-S ngokuvimbela i-CDK4/6-dependent retinoblastoma (RB) phosphorylation.I-Palbociclibhas isetshenziselwe ukwelapha i-HER2 negative, i-estrogen receptor (ER) umdlavuza webele we-metastatic we-metastatic.